Data / Form D filings / RECODE THERAPEUTICS, INC.
RECODE THERAPEUTICS, INC.: Form D filings
RECODE THERAPEUTICS, INC., a biotechnology company in Menlo Park, CA, filed 9 Form D notices with the SEC between 2017 and 2025. The latest, on October 23, 2025, reports $29.4 million sold of a $29.4 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1140 O'Brien Drive, Menlo Park, CA, 94025
- Phone
- (408) 585-1700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1693764
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | New notice | $29,441,931 | $29,441,931 | 26 | Sep 23, 2025 | sec.gov | |
| Sep 28, 2023 | Amendment | $290,000,113 | $259,799,396 | $30,200,717 | 28 | Oct 13, 2021 | sec.gov |
| Jan 27, 2023 | Amendment | $220,801,112 | $210,000,022 | $10,801,090 | 24 | Oct 13, 2021 | sec.gov |
| Jul 6, 2022 | Amendment | $200,000,004 | $160,000,009 | $39,999,995 | 23 | Oct 13, 2021 | sec.gov |
| Oct 25, 2021 | New notice | $80,000,001 | $40,000,042 | $39,999,959 | 20 | Oct 13, 2021 | sec.gov |
| Mar 20, 2020 | New notice | $79,999,973 | $27,499,993 | $52,499,980 | 9 | Mar 6, 2020 | sec.gov |
| Feb 8, 2019 | Amendment | $3,000,000 | $2,000,000 | $1,000,000 | 1 | Dec 16, 2016 | sec.gov |
| Mar 2, 2017 | Amendment | $3,000,000 | $1,000,000 | $2,000,000 | 1 | Dec 16, 2016 | sec.gov |
| Jan 5, 2017 | New notice | $3,000,000 | $500,000 | $2,500,000 | 1 | Dec 16, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rana S. Al-Hallaq | Director | |
| Patricia S. Millican | Director | |
| Shehnaaz Suliman | Executive Officer, Director | |
| Edward S. Hurwitz | Director | |
| Alan S. Colowick | Director | |
| David S. Lockhart | Executive Officer | |
| Dean S. Mitchell | Director | |
| Basheer S. Zada | Director | |
| Inai S. Park | Director | |
| Helen S. Kim | Director | |
| Peter A. Thompson | Director | |
| Rakhshita S. Dhar | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RECODE THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.